Liraglutide for managing overweight and obesity – guidance (TA664)
Liraglutide is recommended for overweight and obesity alongside reduced-calorie diet & increased physical activity in adults, only in patients with non-diabetic hyperglycaemia and a high risk of CVD with a BMI ≥35kg/m2. It should be prescribed by the weight management service.
Source:
National Institute for Health and Care Excellence